Continuous or repeated prolonged cisplatin infusions in children: a prospective study on ototoxicity, platinum concentrations, and standard serum parameters.
about
Different infusion durations for preventing platinum-induced hearing loss in children with cancerDifferent infusion durations for preventing platinum-induced hearing loss in children with cancerHuman OCT2 variant c.808G>T confers protection effect against cisplatin-induced ototoxicity.Identification of genetic and chemical modulators of zebrafish mechanosensory hair cell deathComparison of the effectiveness of monitoring Cisplatin-induced ototoxicity with extended high-frequency pure-tone audiometry or distortion-product otoacoustic emissionTranstympanic Ringer's lactate application in the prevention of cisplatinum-induced ototoxicity in a chinchilla animal model.N-acetylcysteine chemoprotection without decreased cisplatin antitumor efficacy in pediatric tumor models.Molecular mechanisms of resistance and toxicity associated with platinating agents.Platinum-induced ototoxicity: a review of prevailing ototoxicity criteria.Survival trends and long-term toxicity in pediatric patients with osteosarcoma.Prospective evaluation of cisplatin- and carboplatin-mediated ototoxicity in paediatric and adult soft tissue and osteosarcoma patients.Atypical teratoid rhabdoid tumor: improved long-term survival with an intensive multimodal therapy and delayed radiotherapy. The Medical University of Vienna Experience 1992-2012.Do pharmacokinetic polymorphisms explain treatment failure in high-risk patients with neuroblastoma?Hearing loss after platinum treatment is irreversible in noncranial irradiated childhood cancer survivors.Anti-tumor activity of the HSP90 inhibitor SNX-2112 in pediatric cancer cell lines.Front-line window therapy with cisplatin in patients with primary disseminated Ewing sarcoma: A study by the Associazione Italiana di Ematologia ed Oncologia Pediatrica and Italian Sarcoma Group.The plasma and cerebrospinal fluid pharmacokinetics of the platinum analog satraplatin after intravenous administration in non-human primates.The use of high-frequency audiometry increases the diagnosis of asymptomatic hearing loss in pediatric patients treated with cisplatin-based chemotherapy.
P2860
Q24193767-903EFDCB-DBBB-4D33-A6C8-244F7473D317Q26470492-53447AE0-709D-433C-B95D-99977A9B86BEQ27335267-B1D1A472-8CCC-4209-9371-E64F2115403DQ28472316-92B79009-FE21-4265-85A1-2A9E91A17757Q30429268-CB1B0E27-8519-4C6A-B50B-CB2E6A5BAB12Q33629840-B0D7C7D4-143D-49E6-BF3B-4D78E1F24FDAQ35071886-5B6DB2A1-0C58-46BE-A740-3127ECC7FEBEQ35758048-0050C68E-8236-476B-95B2-152658DB57B2Q36035287-93121DC3-A90E-4D4E-9954-4E9EBEDFCE9CQ36440294-7341D644-41A8-424B-A892-4F0369773472Q36475858-4E0CA7D0-7262-47A2-8E0C-72D150F95B1BQ37595251-AA6575B1-6360-46D3-A070-6FEC7B0DE294Q37834445-1AF0DD2C-0A7F-413E-9549-D6AE7A0DF90AQ38738787-E6DA321E-91D9-476C-BBDE-5487204D4237Q39499295-84410C43-9306-403D-8423-9C3DC98A7595Q48280684-F29F4DC1-304B-4E66-A664-D0213945D8D7Q49123833-98DFAB1A-8D32-4B4A-AA98-C9B6BD00FF33Q50430194-BC028179-C1E6-4349-92CD-3FBB45AD2C03
P2860
Continuous or repeated prolonged cisplatin infusions in children: a prospective study on ototoxicity, platinum concentrations, and standard serum parameters.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Continuous or repeated prolong ...... and standard serum parameters.
@en
Continuous or repeated prolong ...... and standard serum parameters.
@nl
type
label
Continuous or repeated prolong ...... and standard serum parameters.
@en
Continuous or repeated prolong ...... and standard serum parameters.
@nl
prefLabel
Continuous or repeated prolong ...... and standard serum parameters.
@en
Continuous or repeated prolong ...... and standard serum parameters.
@nl
P2093
P2860
P356
P1476
Continuous or repeated prolong ...... and standard serum parameters.
@en
P2093
Dinnesen AG
Lanvers-Kaminsky C
Würthwein G
P2860
P304
P356
10.1002/PBC.20673
P577
2006-08-01T00:00:00Z